We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+2.83%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.76B
AUM Growth
+$499M
Cap. Flow
+$366M
Cap. Flow %
4.71%
Top 10 Hldgs %
15.72%
Holding
1,667
New
74
Increased
571
Reduced
929
Closed
86

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$48.8M
2
DOC icon
Healthpeak Properties
DOC
+$16.2M
3
CLX icon
Clorox
CLX
+$16.1M
4
BF.B icon
Brown-Forman Class B
BF.B
+$14.4M
5
HRL icon
Hormel Foods
HRL
+$14.3M

Sector Composition

Rank Sector Weight
1 Healthcare 16.62%
2 Technology 13.27%
3 Financials 13.22%
4 Consumer Staples 11.59%
5 Industrials 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KBR icon
1451
KBR
KBR
$4.45B
$176K ﹤0.01%
13,280
-1,464
-10% -$21.1K
SEM
1452
DELISTED
Select Medical
SEM
$174K ﹤0.01%
29,715
+669
+2% +$4.43K
GLNG icon
1453
Golar LNG
GLNG
$5.05B
$173K ﹤0.01%
+11,192
New +$199K
ZGNX
1454
DELISTED
Zogenix, Inc.
ZGNX
$173K ﹤0.01%
21,472
+252
+1% +$2.46K
CRIS icon
1455
Curis
CRIS
$9.02M
$171K ﹤0.01%
55
+1
+2% +$3.57K
FSP
1456
Franklin Street Properties
FSP
$51.3M
$171K ﹤0.01%
13,938
+888
+7% +$10K
CCXI
1457
DELISTED
ChemoCentryx, Inc.
CCXI
$171K ﹤0.01%
38,159
+2,311
+6% +$8.67K
AKS
1458
DELISTED
AK Steel Holding Corp
AKS
$170K ﹤0.01%
36,524
+9,265
+34% +$40.6K
GNL icon
1459
Global Net Lease
GNL
$1.95B
$166K ﹤0.01%
+6,957
New +$176K
INN
1460
Summit Hotel Properties
INN
$722M
$166K ﹤0.01%
12,544
-125
-1% -$1.49K
DCH
1461
Dauch Corp
DCH
$1.29B
$165K ﹤0.01%
+11,421
New +$178K
LOCK
1462
DELISTED
LifeLock, Inc.
LOCK
$163K ﹤0.01%
10,341
-1,211
-10% -$15.8K
IMUX icon
1463
Immunic
IMUX
$207M
$162K ﹤0.01%
65
+2
+3% +$6.57K
RCKT icon
1464
Rocket Pharmaceuticals
RCKT
$376M
$162K ﹤0.01%
5,452
+601
+12% +$21.1K
SC
1465
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$162K ﹤0.01%
15,700
-68
-0.4% -$789
MDR
1466
DELISTED
McDermott International
MDR
$159K ﹤0.01%
10,699
+417
+4% +$5.63K
TXMD icon
1467
TherapeuticsMD
TXMD
$23.8M
$156K ﹤0.01%
367
+15
+4% +$6.18K
CMRX
1468
DELISTED
Chimerix, Inc.
CMRX
$156K ﹤0.01%
39,622
-154
-0.4% -$761
GSAT icon
1469
Globalstar
GSAT
$10.2B
$154K ﹤0.01%
8,462
+59
+0.7% +$1.57K
TPST icon
1470
Tempest Therapeutics
TPST
$15.4M
$154K ﹤0.01%
10
+2
+25% +$45.7K
EXPR
1471
DELISTED
Express, Inc.
EXPR
$154K ﹤0.01%
532
-67
-11% -$22.5K
BPFH
1472
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$151K ﹤0.01%
12,855
-1,386
-10% -$16.7K
DCOY
1473
Decoy Therapeutics
DCOY
$2.98M
0
SDRL
1474
DELISTED
Seadrill Limited Common Stock
SDRL
$150K ﹤0.01%
+173
New +$165K
AROC icon
1475
Archrock
AROC
$6.51B
$149K ﹤0.01%
15,861
-1,306
-8% -$10.3K

Similar funds

ProShare Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, ProShare Advisors held 1,667 positions worth $7.76B, up 6.9% from $7.26B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

ProShare Advisors deployed $366M of net new capital in Q2 2016, opening 74 new positions and adding to 571 existing holdings. Its largest new stake was S&P Global: 454,450 shares worth $48.7M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Apple, an estimated $10.8M trimmed.

  • ProShare Advisors's largest Q2 2016 buy was S&P Global: 454,450 shares worth $48.7M.
  • ProShare Advisors added most to Healthpeak Properties in Q2 2016, an estimated $16.2M increase.
  • ProShare Advisors's biggest Q2 2016 reduction was Apple, cutting an estimated $10.8M.
  • ProShare Advisors fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $36.9M.
  • ProShare Advisors's ten largest holdings make up 16% of its $7.76B portfolio in Q2 2016.
  • ProShare Advisors opened 74 new positions and closed 86 in Q2 2016.
  • ProShare Advisors's portfolio value rose 6.9% quarter-over-quarter to $7.76B.

Based on ProShare Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.